Annual ROE:
54.39%+82.98%(+290.24%)Summary
- As of today, PTGX annual return on equity is 54.39%, with the most recent change of +82.98% (+290.24%) on December 31, 2024.
- During the last 3 years, PTGX annual ROE has risen by +97.71% (+225.55%).
- PTGX annual ROE is now at all-time high.
Performance
PTGX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
8.38%-0.99%(-10.57%)Summary
- As of today, PTGX quarterly return on equity is 8.38%, with the most recent change of -0.99% (-10.57%) on June 30, 2025.
- Over the past year, PTGX quarterly ROE has dropped by -33.38% (-79.93%).
- PTGX quarterly ROE is now -83.89% below its all-time high of 52.01%, reached on December 31, 2024.
Performance
PTGX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PTGX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +290.2% | -79.9% |
| 3Y3 Years | +225.6% | +119.7% |
| 5Y5 Years | +167.8% | +111.2% |
PTGX ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +210.1% | -83.9% | +114.9% |
| 5Y | 5-Year | at high | +167.8% | -83.9% | +114.9% |
| All-Time | All-Time | at high | +132.1% | -83.9% | +108.4% |
PTGX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | 8.38%(-10.6%) |
| Mar 2025 | - | 9.37%(-82.0%) |
| Dec 2024 | 54.39%(+290.2%) | 52.01%(+38.4%) |
| Sep 2024 | - | 37.59%(-10.0%) |
| Jun 2024 | - | 41.76%(-11.9%) |
| Mar 2024 | - | 47.41%(+263.9%) |
| Dec 2023 | -28.59%(+42.1%) | -28.93%(+47.6%) |
| Sep 2023 | - | -55.24%(+0.6%) |
| Jun 2023 | - | -55.60%(+1.2%) |
| Mar 2023 | - | -56.29%(-17.4%) |
| Dec 2022 | -49.41%(-14.1%) | -47.93%(-6.3%) |
| Sep 2022 | - | -45.08%(-5.8%) |
| Jun 2022 | - | -42.61%(-7.7%) |
| Mar 2022 | - | -39.56%(+3.8%) |
| Dec 2021 | -43.32%(-17.7%) | -41.14%(-6.8%) |
| Sep 2021 | - | -38.52%(-16.6%) |
| Jun 2021 | - | -33.03%(+11.5%) |
| Mar 2021 | - | -37.32%(+14.3%) |
| Dec 2020 | -36.79% | -43.56%(+22.6%) |
| Sep 2020 | - | -56.31%(+24.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -74.94%(+23.7%) |
| Mar 2020 | - | -98.27%(-20.4%) |
| Dec 2019 | -80.20%(-140.2%) | -81.60%(-14.7%) |
| Sep 2019 | - | -71.14%(-14.3%) |
| Jun 2019 | - | -62.23%(-53.5%) |
| Mar 2019 | - | -40.54%(-20.7%) |
| Dec 2018 | -33.39%(+5.9%) | -33.59%(-25.4%) |
| Sep 2018 | - | -26.79%(-2.3%) |
| Jun 2018 | - | -26.20%(+26.3%) |
| Mar 2018 | - | -35.57%(+22.6%) |
| Dec 2017 | -35.50%(+53.6%) | -45.97%(+22.9%) |
| Sep 2017 | - | -59.60%(+14.2%) |
| Jun 2017 | - | -69.44%(-7.8%) |
| Mar 2017 | - | -64.44%(-0.5%) |
| Dec 2016 | -76.53%(+54.8%) | -64.14%(-7.8%) |
| Sep 2016 | - | -59.52%(+40.6%) |
| Jun 2016 | - | -100.27%(-53.6%) |
| Mar 2016 | - | -65.30%(-132.3%) |
| Dec 2015 | -169.31%(-21.6%) | -28.11% |
| Dec 2014 | -139.18% | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual ROE year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly ROE year-on-year change?
What is Protagonist Therapeutics, Inc. annual return on equity?
The current annual ROE of PTGX is 54.39%
What is the all-time high annual ROE for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual return on equity is 54.39%
What is Protagonist Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, PTGX annual return on equity has changed by +82.98% (+290.24%)
What is Protagonist Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of PTGX is 8.38%
What is the all-time high quarterly ROE for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly return on equity is 52.01%
What is Protagonist Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, PTGX quarterly return on equity has changed by -33.38% (-79.93%)